Clinical Trial Update: COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial update for a COVID-19 vaccine studied in immunosuppressed adults with autoimmune diseases, currently completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Diseases
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Covid19, Rheumatic Diseases | Phase 3 | Status: COMPLETED